Dexbrompheniramine and pseudoephedrine and Iodotope
Determining the interaction of Dexbrompheniramine and pseudoephedrine and Iodotope and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Dexbrompheniramine may affect the diagnostic results of sodium iodide I-131. Talk to your doctor before you are scheduled for testing to find out if and for how long you should stop using dexbrompheniramine so that it does not interfere with sodium iodide I-131 test results. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:ADJUST DOSING INTERVAL: Certain drugs may affect the pharmacokinetics, pharmacodynamics, and/or diagnostic results of radioiodides.
MANAGEMENT: Antithyroid agents such as carbimazole or propylthiouracil should generally be withheld for 1 week before administration of sodium iodide I-131 or I-123, and for a few days afterward. Salicylates, steroids, anticoagulants, antihistamines, antiparasitics, penicillins, sulfonamides, tolbutamide, thiopental, and nitroprusside should generally be withheld for 1 week. Amiodarone, lithium, and benzodiazepines should be withheld for at least 4 weeks.
- "Product Information. Sodium Iodide I-123 (sodium iodide I-123)." GE Healthcare, Princeton, NJ.
Generic Name: dexbrompheniramine / pseudoephedrine
Brand name: Ala Hist PE, Ala-Hist PE, Conex, Drixoral Cold and Allergy, Drexophed SR, Desihist SA, Duomine, Dexophed, Disobrom, Disophrol, Drixoral, 12 Hour Cold, Dexaphen SA, Dixaphedrine, Drixomed, Pharmadrine, Drixoral Sinus
Synonyms: Brompheniramine and Pseudoephedrine Drops
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexbrompheniramine and pseudoephedrine-Ioflupane i 123 Intravenous
- Dexbrompheniramine and pseudoephedrine-Ioflupane I-123
- Dexbrompheniramine and pseudoephedrine-Iohexol
- Dexbrompheniramine and pseudoephedrine-Iohexol Injection, Oral, Rectal
- Dexbrompheniramine and pseudoephedrine-Ionamin
- Dexbrompheniramine and pseudoephedrine-Ionil Plus
- Iodotope-Dexbrompheniramine and Pseudoephedrine Solution
- Iodotope-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Iodotope-Dexbrompheniramine and Pseudoephedrine Tablets
- Iodotope-Dexbrompheniramine Tablets
- Iodotope-Dexbrompheniramine, dextromethorphan, and phenylephrine
- Iodotope-Dexbrompheniramine, Dextromethorphan, and Phenylephrine Liquid